Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

MAF anticorps (AA 270-320) (PE)

Cet anticorps anti-MAF est un anticorps Lapin Polyclonal détectant MAF dans FACS. Adapté pour Humain, Souris et Rat.
N° du produit ABIN2170731

Aperçu rapide pour MAF anticorps (AA 270-320) (PE) (ABIN2170731)

Antigène

Voir toutes MAF Anticorps
MAF (V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog (Avian) (MAF))

Reactivité

  • 59
  • 49
  • 21
  • 6
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
Humain, Souris, Rat

Hôte

  • 67
  • 4
Lapin

Clonalité

  • 64
  • 7
Polyclonal

Conjugué

  • 40
  • 5
  • 4
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp MAF est conjugé à/à la PE

Application

  • 43
  • 26
  • 13
  • 13
  • 13
  • 7
  • 5
  • 4
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
Flow Cytometry (FACS)
  • Épitope

    • 15
    • 10
    • 9
    • 7
    • 5
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 270-320

    Purification

    Purified by Protein A.

    Immunogène

    KLH conjugated synthetic peptide derived from human c-Maf

    Isotype

    IgG
  • Indications d'application

    FCM(1:20-100)

    Commentaires

    Exitation/Emission: 480,565nm/578nm

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 μg/μL

    Buffer

    Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    Store at 4°C

    Date de péremption

    12 months
  • Antigène

    MAF (V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog (Avian) (MAF))

    Autre désignation

    C-Maf

    Sujet

    Acts as a transcriptional activator or repressor. Involved in embryonic lens fiber cell development. Recruits the transcriptional coactivators CREBBP and/or EP300 to crystallin promoters leading to up-regulation of crystallin gene during lens fiber cell differentiation. Activates the expression of IL4 in T helper 2 (Th2) cells. Increases T-cell susceptibility to apoptosis by interacting with MYB and decreasing BCL2 expression. Together with PAX6, transactivates strongly the glucagon gene promoter through the G1 element. Activates transcription of the CD13 proximal promoter in endothelial cells. Represses transcription of the CD13 promoter in early stages of myelopoiesis by affecting the ETS1 and MYB cooperative interaction. Involved in the initial chondrocyte terminal differentiation and the disappearance of hypertrophic chondrocytes during endochondral bone development. Binds to the sequence 5'-[GT]G[GC]N[GT]NCTCAGNN-3' in the L7 promoter. Binds to the T-MARE (Maf response element) sites of lens-specific alpha- and beta-crystallin gene promoters. Binds element G1 on the glucagon promoter. Binds an AT-rich region adjacent to the TGC motif (atypical Maf response element) in the CD13 proximal promoter in endothelial cells (By similarity). When overexpressed, represses anti-oxidant response element (ARE)-mediated transcription. Involved either as an oncogene or as a tumor suppressor, depending on the cell context. Binds to the ARE sites of detoxifying enzyme gene promoters.

    Subcellular location: Nucleus


    Synonyms: CCA4, c-MAF, Transcription factor Maf, Proto-oncogene c-Maf, V-maf musculoaponeurotic fibrosarcoma oncogene homolog, MAF

    ID gène

    4094

    UniProt

    O75444
Vous êtes ici:
Chat with us!